EULAR 2023 Insights


 

EULAR 2023 Insights: Benralizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA) - Results From a European Multicenter Study

72 views
June 15, 2023
Comments 0
Login to view comments. Click here to Login